Berlin, Germany – A concerning outbreak of Lassa fever is currently unfolding in Nigeria, with a significant rise in cases and fatalities reported since the beginning of 2026. As of early March, the Nigeria Centre for Disease Control (NCDC) has confirmed 469 cases and 109 deaths, raising alarm among health officials and prompting intensified response efforts. This surge in infections underscores the ongoing threat posed by this viral hemorrhagic fever, particularly in West African nations.
Lassa fever, named after the town of Lassa in Borno State, Nigeria, where it was first discovered in 1969, is a zoonotic disease, meaning it’s transmitted from animals to humans. Rodents, specifically the multimammate rat (Mastomys natalensis), serve as the primary reservoir for the Lassa virus. Human infection typically occurs through contact with rodent excreta or saliva, or through direct contact with infected individuals. The disease is endemic in several West African countries, including Nigeria, Sierra Leone, Liberia, and Guinea.
Rising Cases and Geographic Distribution
The NCDC’s recent epidemiological report details a worrying trend. Between February 23rd and March 1st, 2026, 2,446 suspected cases of Lassa fever were reported across 18 of Nigeria’s 36 states. The confirmed cases and fatalities represent a case fatality rate of 23.2%. This is a significant public health concern, demanding immediate and coordinated action.
The states most heavily affected by the outbreak are concentrated in specific regions of the country. Bauchi State in the northeast accounts for 28% of confirmed cases, followed by Ondo State in the southwest (22%), Taraba State in the east (19%), Benue State in the central region (9%), and Edo State in the south (8%). A particularly vulnerable demographic has been identified: young women aged 21 to 30 years. The reasons for this disproportionate impact are complex and likely involve a combination of factors, including occupational exposure and household responsibilities.
Symptoms, Diagnosis, and Treatment
Lassa fever presents with a wide range of symptoms, making early diagnosis challenging. The initial stages of the illness often mimic other common febrile illnesses, such as malaria or typhoid fever. Common symptoms include headache, fever, general weakness, and malaise. As the disease progresses, patients may experience vomiting, diarrhea, abdominal pain, and bleeding from gums, nose, or other orifices. In severe cases, Lassa fever can lead to neurological complications, including hearing loss, tremors, and encephalitis.
The incubation period for Lassa fever typically ranges from 6 to 21 days. Accurate and timely diagnosis is crucial for effective management. Laboratory confirmation is achieved through detecting the virus, viral RNA, or antibodies in patient samples. The gold standard for treatment remains the antiviral drug ribavirin. The Centers for Disease Control and Prevention (CDC) emphasizes that early administration of ribavirin significantly improves survival rates.
Challenges and Response Efforts
Despite ongoing efforts to control the outbreak, several challenges hinder effective response. The NCDC reports that delays in seeking medical care, often due to the high cost of treatment, contribute to increased morbidity, and mortality. Limited access to healthcare facilities, particularly in rural areas, further exacerbates the problem.
Poor sanitation and inadequate hygiene practices also play a significant role in the transmission of Lassa fever. The presence of rodents in homes and food storage areas increases the risk of exposure. A lack of awareness about the disease and its modes of transmission contributes to its spread. Alarmingly, the NCDC has also noted an increase in infections among healthcare workers, highlighting the need for enhanced infection prevention and control measures within healthcare settings. Recent reports indicate six healthcare workers were infected within a single week, underscoring the occupational risk.
The NCDC is actively working to contain the outbreak through a variety of interventions. These include strengthening surveillance systems, providing laboratory support, implementing infection prevention and control measures, and conducting risk communication and community mobilization activities. Collaboration with state governments, international partners, and local communities is essential for a coordinated and effective response. The agency is urging closer collaboration between the government and its partners to bolster the capacity of states to prevent, detect, and respond swiftly to the outbreak.
The Wider Regional Context
The current outbreak in Nigeria is part of a broader pattern of Lassa fever activity in West Africa. According to the Africa Centres for Disease Control and Prevention (Africa CDC), between 100,000 and 300,000 Lassa fever infections occur annually in West Africa, resulting in approximately 5,000 deaths. The disease remains a significant public health challenge in the region, requiring sustained investment in surveillance, research, and control measures.
The Africa CDC emphasizes the importance of a One Health approach, which recognizes the interconnectedness of human, animal, and environmental health. Controlling Lassa fever requires addressing the underlying ecological factors that contribute to its transmission, such as rodent populations and environmental sanitation.
Preventive Measures and Public Health Recommendations
Preventing Lassa fever relies on a multi-pronged approach. Key preventive measures include:
- Rodent Control: Implementing effective rodent control measures in homes and communities. This includes proper food storage, waste management, and the use of rodenticides.
- Personal Hygiene: Practicing good personal hygiene, such as frequent handwashing with soap and water.
- Safe Food Handling: Thoroughly cooking all food, especially meat, and avoiding contact with rodent excreta.
- Healthcare Worker Protection: Ensuring that healthcare workers have access to appropriate personal protective equipment (PPE) and are trained in infection prevention and control practices.
- Community Awareness: Raising public awareness about Lassa fever, its symptoms, and modes of transmission.
The NCDC urges healthcare professionals to maintain a high level of suspicion for Lassa fever, particularly in patients presenting with fever, headache, and other non-specific symptoms. Prompt diagnosis and treatment are critical for improving patient outcomes.
The NCDC is expected to release its next epidemiological report in early April 2026, providing an updated assessment of the outbreak situation. Continued monitoring and surveillance are essential for tracking the spread of the disease and informing public health interventions. Readers are encouraged to stay informed about the latest developments and follow the guidance of public health authorities.